Epstein–Barr virus: more than 50 years old and still providing surprises

LS Young, LF Yap, PG Murray - Nature reviews cancer, 2016 - nature.com
It is more than 50 years since the Epstein–Barr virus (EBV), the first human tumour virus, was
discovered. EBV has subsequently been found to be associated with a diverse range of …

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

AB Rickinson, DJ Moss - Annual review of immunology, 1997 - annualreviews.org
▪ Abstract Epstein-Barr virus (EBV) provides one of the most informative systems with which
to study cytotoxic T lymphocyte (CTL) responses in humans. The virus establishes a highly …

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.

JI Cohen, F Wang, J Mannick… - Proceedings of the …, 1989 - National Acad Sciences
Epstein-Barr virus (EBV) efficiently transforms B lymphocytes to perpetual proliferation. The
EBV laboratory strain P3HR-1 is transformation-incompetent and lacks a DNA segment that …

Expression of Epstein–Barr virus transformation–associated genes in tissues of patients with EBV lymphoproliferative disease

L Young, C Alfieri, K Hennessy, H Evans… - … England Journal of …, 1989 - Mass Medical Soc
Epstein–Barr virus (EBV) has been associated with serious or fatal lymphoproliferative
disease in immunocompromised patients. EBV nuclear protein 2 and latent membrane …

Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers

R Elkington, S Walker, T Crough, M Menzies… - Journal of …, 2003 - Am Soc Microbiol
Human cytomegalovirus (HCMV) can establish both nonproductive (latent) and productive
(lytic) infections. Many of the proteins expressed during these phases of infection could be …

The pathogenesis of Burkitt's lymphoma

I Magrath - Advances in cancer research, 1990 - Elsevier
Publisher Summary This chapter discusses the evidence that deregulation of c-myc is a
critical component of the pathogenesis of Burkitt's lymphoma, and consideration is given to …

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.

RJ Murray, MG Kurilla, JM Brooks… - The Journal of …, 1992 - rupress.org
Epstein-Barr virus (EBV), a human herpes virus with oncogenic potential, persists in B
lymphoid tissues and is controlled by virus-specific cytotoxic T lymphocyte (CTL) …

Durable complete response from metastatic melanoma after transfer of autologous T cells recognizing 10 mutated tumor antigens

TD Prickett, JS Crystal, CJ Cohen, A Pasetto… - Cancer immunology …, 2016 - AACR
Immunotherapy treatment of patients with metastatic cancer has assumed a prominent role
in the clinic. Durable complete response rates of 20% to 25% are achieved in patients with …

Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease

R Khanna, S Bell, M Sherritt… - Proceedings of the …, 1999 - National Acad Sciences
The treatment of Epstein–Barr virus (EBV)-associated lymphoproliferative disease (PTLD) in
EBV seronegative solid organ transplant recipients who acquire their EBV infection after …

Human herpesviruses: a consideration of the latent state

JG Stevens - Microbiological reviews, 1989 - Am Soc Microbiol
Taken together, herpesviruses that infect humans are responsible for multiple syndromes
involving many organ systems. Aside from a similar ultrastructural morphology and some …